CRCINA -Centre de recherche en cancérologie et immunologie Nantes-Angers

Type: Research unit evaluation report

Evaluation campaign: 2015-2016 (group B) - Published on: 19/05/2016

Institution(s) concerned: Université de Nantes , Centre national de la recherche scientifique - CNRS , Institut national de la santé et de la recherche médicale - INSERM , Université d'Angers

Disciplinary research field: Life and Earth Sciences (SVE) ; SVE3 Microbiology, Virology, Immunity ; SVE2 Cellular Biology, Imaging, Molecular Biology, Biochemistry, Genomics, Systemic Biology, Development, Structural Biology

Scientific field(s): 5 - Biologie, medecine et santé

ERC panel(s): Autre

Name of unit teams: Immunobiology of Human __ and __ T cells and immunotherapeutic applications ; Clinical and translational research in skin cancer ; Anti-tumor T cell responses and immunotherapy ; Immunogenic cell death in cancer treatments (mesothelioma)   ; Host-pathogen interactions in the régulation of immune responses - ; IL-15 and receptors in Immuno-cancérology ; Innate immunity and Immunotherapy ; Stress Adpatation and Tumor Escape in breast cancer ; Apoptosis and tumor progression ; Regulation of Bcl2 and p53 networks in Multiple Myeloma and Mantle Cell Lymphoma ; Integrative oncogenomics of multiple myeloma pathogenesis and progression ; Senescence escape and soluble markers of cancer progression ; Nuclear Oncology ; Endothelium radiobiology and targeting ; Signaling in Oncogenesis, Angiogenesis and Permeability ; Molecular Mechanisms of chronic Inflammation in Hematological Diseases ; AVENIR/ ATOMycA ; Design of particulate systems for local treatment in glioblastoma

Keywords: ONCOLOGIE ; APOPTOSE ; THERAPIE CIBLEE ; THERAPIE CELLULAIRE ; RADIOELEMENTS ; SVE2_3 ; SVE6